About this trial
This randomized controlled trial evaluates whether intraoperative guidance using the CoreSys monitor reduces the surgical stress response in patients undergoing elective open abdominal hysterectomy. Surgical stress involves complex hemodynamic, endocrine, and inflammatory responses that may negatively impact postoperative recovery.
Patients will be randomized to either anesthesia guided by conventional clinical and hemodynamic parameters or anesthesia additionally guided by CoreSys-derived indices of consciousness, nociception, and stress activity. The primary objective is to assess whether CoreSys-guided anesthesia attenuates stress biomarkers, including interleukin-6 (IL-6), cortisol and glycemia.
Eligibility criteria
Qualifiers
Female patients aged 18-70 years
Scheduled elective open abdominal hysterectomy in the morning
Written informed consent
Disqualifiers
Refusal to participate
Significant endocrine/metabolic disease
Pacemaker or major arrhythmias
Contraindication to epidural anesthesia
Trial design
Treatments tested in this trial
- propofol
- CoreSys Monitor
- Remifentanil (Target-Controlled Infusion)
Treatment groups
Sponsors and collaborators
Hospital Provincial de Rosario
Lead sponsor
Coresys Health
Collaborator